pamidronate has been researched along with Granulocytic Leukemia, Chronic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kuroda, J | 1 |
| Kimura, S | 1 |
| Segawa, H | 1 |
| Kobayashi, Y | 1 |
| Yoshikawa, T | 1 |
| Urasaki, Y | 1 |
| Ueda, T | 1 |
| Enjo, F | 1 |
| Tokuda, H | 1 |
| Ottmann, OG | 1 |
| Maekawa, T | 1 |
| Sawyer, N | 1 |
| Newstead, C | 1 |
| Drummond, A | 1 |
| Newland, A | 1 |
| Cunningham, J | 1 |
2 other studies available for pamidronate and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
The third-generation bisphosphonate zoledronate synergistically augments the anti-Ph+ leukemia activity of imatinib mesylate.
Topics: Animals; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; | 2003 |
One-shot high-dose pamidronate disodium (APD): effective, simple treatment for hypercalcaemia in haematological malignancy.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Diphosphonates; Drug Administration Schedule; | 1989 |